Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 11Carcinoma, Intraductal, Noninfiltrating 4Carcinoma, Ductal, Breast 3Breast Carcinoma In Situ 2Stomach Neoplasms 1Skin Abnormalities 1Radiodermatitis 1Radiation Injuries 1Pancreatic Neoplasms 1Pain 1Ovarian Neoplasms 1Neoplasms 1Neoplasm Metastasis 1Melanoma 1Liver Neoplasms 1Inflammation 1Fatigue 1Depression 1Colorectal Neoplasms 1Colonic Neoplasms 1Carcinoma, Ovarian Epithelial 1Carcinoma, Lobular 1Carcinoma, Hepatocellular 1Anatomic Stage II Breast Cancer AJCC v8 1

Interventions

Paclitaxel 26pembrolizumab 24Docetaxel 20Capecitabine 19Fulvestrant 17Trastuzumab 16Anastrozole 15Cyclophosphamide 14Lapatinib 13Letrozole 11Carboplatin 11Radiotherapy 10Doxorubicin 10palbociclib 9Therapeutics 9Nivolumab 9Exercise 9Gemcitabine 8Cisplatin 8Blood Specimen Collection 8Tamoxifen 7Bevacizumab 7liposomal doxorubicin 6exemestane 6abemaciclib 6Vinorelbine 6Standard of Care 6Fluorouracil 6ribociclib 5atezolizumab 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasms × Radiotherapy, Conformal × Breast × Clear all
NCT02276885 2025-12-30

Prone Partial Breast Irradiation (PBI): a Prospective Randomized Trial

NYU Langone Health

Phase NA Active not recruiting
284 enrolled 10 charts
Breast

Breast Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡